Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2008-04-24 Interim / Quarterly Rep…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY–MARCH 2008' and contains comprehensive financial statements, including a summary of net sales, losses, cash flow, and balance sheet items for the specified period. It also includes detailed management commentary on business operations, R&D progress, and project portfolios. It is a full quarterly report, not an announcement or a summary, and thus fits the definition of an Interim/Quarterly Report (IR). Q1 2008
2008-04-24 English
Earnings Release 2008
Earnings Release Classification · 95% confidence The document is a press release announcing positive results from the first phase I clinical study of a compound (KB3305) for type 2 diabetes. It details preliminary findings (pharmacokinetics, safety) and outlines the next steps in the clinical program (Multiple Ascending Dose study, efficacy study in patients). This content aligns best with an Earnings Release (ER) which typically covers recent operational and clinical milestones, or potentially an Investor Presentation (IP) if it were structured as slides, but given the format and focus on recent results, ER is the closest fit among the options for a general announcement of performance/progress. It is not a full Annual Report (10-K), a formal Audit Report (AR), or a specific regulatory filing like DIRS or DIV. Since it announces key results, ER is the most appropriate classification. FY 2008
2008-04-17 English
Legal Proceedings Report 2008
Legal Proceedings Report Classification · 99% confidence The document is a press release dated April 17, 2008, announcing positive results from the first clinical study of the diabetes drug candidate KB3305. It details the study's progress (Phase I completion, robust pharmacokinetics, no serious side effects) and outlines the next steps (repeated dosing, Phase IIa in diabetic patients). This content—a specific update on clinical trial progress and drug development—is characteristic of an announcement intended for investors and the market regarding the company's pipeline progress. It is not a full Annual Report (10-K), a comprehensive Interim Report (IR), a formal Earnings Release (ER) focusing on revenue/profit, or a transcript (CT). It is a specific corporate update related to R&D progress. Given the options, this fits best as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but as a press release detailing R&D milestones, RNS is the most appropriate general category for non-standard, material corporate news that isn't explicitly covered by other codes like ER or IR. Since it is a specific announcement of a clinical trial milestone, and not a general regulatory filing fallback, I will check if it fits better elsewhere. It is not a financing update (CAP), management change (MANG), or dividend notice (DIV). It is a material update on the product pipeline. In the absence of a specific 'Clinical Trial Update' code, RNS (Regulatory Filings/Announcements) serves as the best fit for this type of material press release.
2008-04-17 Swedish
Annual Report 2007
Annual Report Classification · 100% confidence The document is titled 'ÅRSREDOVISNING 2007' (Annual Report 2007) for the company 'Karo Bio'. It contains a comprehensive overview of the company's activities, financial statements (Resultaträkningar, Balansräkningar, Kassaflödesanalyser), management commentary (VD har ordet), and audit information (Revisionsberättelse). It is clearly the full annual report for the fiscal year 2007, not an announcement or a summary. FY 2007
2008-04-07 Swedish
Report Publication Announcement 2008
Report Publication Announcement Classification · 99% confidence The document explicitly states, "THE ANNUAL REPORT FOR 2007 NOW AVAILABLE ON THE KARO BIO WEB SITE" and provides instructions on how to obtain the printed version. The document itself is very short (2090 characters) and serves primarily to announce the availability of the full Annual Report, rather than containing the comprehensive financial data of the report itself. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement about the publication of a report should be classified as a Report Publication Announcement (RPA).
2008-04-07 English
Report Publication Announcement 2008
Report Publication Announcement Classification · 99% confidence The document is a short announcement dated April 7, 2008, with the headline in Swedish: "KARO BIOS ÅRSREDOVISNING FÖR 2007 TILLGÄNGLIG PÅ BOLAGETS HEMSIDA" (Karo Bio's Annual Report for 2007 available on the company's website). The text explicitly states that the Annual Report (årsredovisning) for 2007 is now available on the website and describes how to obtain the printed version. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document whose primary purpose is to announce the publication of a full report (like an Annual Report) should be classified as a Report Publication Announcement (RPA), not the report itself (10-K). The document is very short (1999 chars) and serves only to announce the availability of the full Annual Report.
2008-04-07 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.